Science & Research

Synergy High Risk AMD Study

A world-leading multidisciplinary research project, investigating age-related macular degeneration and the factors that make some people more likely to lose their vision.

The Synergy High Risk Age-related Macular Degeneration (AMD) Study is a five-year project that aims to determine the causes and genetic associations of a high-risk form of AMD – reticular pseudodrusen (RPD), also known as subretinal drusenoid deposits.

Through this, we aim to achieve a better understanding of the pathways that lead to high-risk AMD and its progression.

The study is led by the Centre for Eye Research Australia (CERA) in partnership with the University of Melbourne, the Walter and Eliza Hall Institute of Medical Research and international collaborators.

Learn more

Our research program

Learn about the background, aims, hypotheses and research themes of the multidisciplinary Synergy High Risk AMD Study.

Our research team

Meet the world-class researchers from CERA, the University of Melbourne and the Walter and Eliza Hall Institute of Medical Research collaborating on this study.

Get involved

Find out how patients can express interest in taking part in our research, and how healthcare practitioners can refer a patient to us.

For further information about the study, please contact:


Dr Carla Abbott
Synergy High Risk AMD Study Project Manager
Email: c.abbott@unimelb.edu.au
Phone: +61 3 9929 8380